Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lennard Wendlinger

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
EJNMMI Radiopharmacy and Chemistry|March 21, 2024
Validation of a size exclusion method for concomitant purification and formulation of peptide radiopharmaceuticalsSebastian Martin, Lennard Wendlinger, Alexandra Litvinenko, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 23, 2025
Novel radiohybrid PET-Tracers for SST<sub>2</sub>-targeted imaging of neuroendocrine tumorsLennard Wendlinger, Mara Parzinger, Alexandra Litvinenko, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 10, 2026
Challenges in tracer development for tumor microenvironment (TME) imagingSebastian Martin, Lennard Wendlinger, Hélène Koch, et al.
EJNMMI Research|August 28, 2024
Validation of the C-X-C chemokine receptor 3 (CXCR3) as a target for PET imaging of T cell activationSebastian Martin, Lennard Wendlinger, Béatrice Zitti, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
EJNMMI Radiopharmacy and Chemistry|March 21, 2024
Validation of a size exclusion method for concomitant purification and formulation of peptide radiopharmaceuticalsSebastian Martin, Lennard Wendlinger, Alexandra Litvinenko, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 23, 2025
Novel radiohybrid PET-Tracers for SST<sub>2</sub>-targeted imaging of neuroendocrine tumorsLennard Wendlinger, Mara Parzinger, Alexandra Litvinenko, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 10, 2026
Challenges in tracer development for tumor microenvironment (TME) imagingSebastian Martin, Lennard Wendlinger, Hélène Koch, et al.
EJNMMI Research|August 28, 2024
Validation of the C-X-C chemokine receptor 3 (CXCR3) as a target for PET imaging of T cell activationSebastian Martin, Lennard Wendlinger, Béatrice Zitti, et al.
Pageof 1